Panel Discussion: Tackling the rising threat of AMR by accelerating R&D

This panel discussion aims to reveal different perspectives on advances and challenges of R&D (Research & Development) targeting AMR. It will also bring to the fore the different needs from basic research to drug development and identify gaps in the global AMR R&D ecosystem, which policy should address.

Opening Remarks:

Prof. Dr. Veronika von Messling, Director General - Life Science Division at the Federal Ministry of Education and Research, Germany

Moderation: 

Laura Jung, MD & Global Health Consultant, Infectious Disease Researcher at the University of Leipzig Medical Center

Panelists:                            

• Dzintars Gotham, Researcher, Policy Consultant, MD · Global Health, Pharmaceuticals, R&D
• Dr Ishwar Singh, CEIDR Chair of AMR Research at the University of Liverpool
• Dr Jeniffer Cohn, Global Access Project Leader, GARDP
• Ruxandra Draghia Akli, Global Head, Global Public Health R&D at The Janssen Pharmaceutical Companies of Johnson & Johnson     

Panel discussion by the Hub Community on AMR

Join the MS Teams Meeting